Supplies of the drug remdesivir have run short more than once. But despite disappointing WHO trial results, European doctors still plan on using it – for now.
As Covid-19 surges across Europe, countries fear drug shortages
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over